News + Filings IR Vault
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results CC transcript Inv. presentation Appointed director Director departure Credit agrmnt [a] Asset disposition Acq. announced Appointed CFO Consulting agrmnt Auditor change Notes underwriting agrmnt Director comp. Employment agrmnt Dividend declared Appointed COO Filed Chapter 11 Monthly dividend Preliminary results Accel. buyback Cert. of designation Acq. completed Monthly oper. report Merger agrmnt [a] Quarterly results presentation Class action filed CFO resigned Departure of a VP SSS news release Asset acq. complete Letter to company Buyback announced Bonus plan approved Upcoming conference date Notes have priced Coll. bargaining agrmnt 10-Q late filing RE purchase Amended bylaws New credit facility
|
All Companies
|
Create: Portfolio | Alert |
All | News | Filings
Date Filed | Symbol | Type | Description |
08/18/2023 |
XSNX
|
8-K
| Quarterly results |
08/08/2023 |
******
|
8-K
| Entered into an underwriting agreement for the issuance and sale of notes |
07/27/2023 |
******
|
8-K
| Director compensation was amended/approved, Entered into an underwriting agreement for the issuance and sale of notes
Docs:
|
"THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF PRIVETERRA ACQUISITION CORP. Priveterra Acquisition Corp. , a corporation organized and existing under the General Corporation Law of the State of Delaware , does hereby certify as follows: 1.            The name of the Corporation is Priveterra Acquisition Corp. The Corporation was incorporated under the name Priveterra Acquisition Corp. by the filing of its original Certificate of Incorporation with the Secretary of State of the State of Delaware on November 17, 2020 and is being amended and restated to reflect that the Corporation has changed its name. 2.             An amended and resta...",
"AEON Biopharma, Inc. as of July 21, 2023",
"AEON BIOPHARMA, INC. AMENDED AND RESTATED 2019 INCENTIVE AWARD PLAN Effective July 21, 2023 AEON BIOPHARMA, INC. AMENDED AND RESTATED 2019 INCENTIVE AWARD PLAN 1.             Purposes of the Plan . The purposes of this AEON Biopharma, Inc. Amended and Restated 2019 Incentive Award Plan are to attract and retain the best available personnel for positions of substantial responsibility, to provide additional incentives to Employees, Directors and Consultants and to promote the success of the Company’ s business. Options granted under the Plan may be Incentive Stock Options or Non-Qualified Stock Options, as determined by the Administrator at the time of grant. Stock Appreciation Rights, Stock Purchase Rights, Restri...",
"2 subject thereto upon the date of Optionee’s termination. II. AGREEMENT 1. Grant of Option. The Company hereby grants to Optionee an Option to purchase the number of Shares set forth in the Notice of Grant, at the exercise price per Share set forth in the Notice of Grant . Notwithstanding anything to the contrary anywhere else in this Stock Option Agreement, the Option is subject to the terms, definitions and provisions of the Plan adopted by the Company, which is incorporated herein by reference. If designated in the Notice of Grant as an Incentive Stock Option, the Option is intended to qualify as an incentive stock option as defined in Section 422 of the Code; provided, however, that to the extent that the aggregate Fair Market Value of stock with respect to which incentive stock optio...",
"US-DOCS\140721846.3 EXHIBIT A RESTRICTED STOCK UNIT AGREEMENT Capitalized terms not specifically defined in this Restricted Stock Unit Agreement have the meanings specified in the Grant Notice or, if not defined in the Grant Notice, in the Plan. ARTICLE I. GENERAL 1.1 Award of RSUs. The Company has granted the RSUs to Participant effective as of the Grant Date set forth in the Grant Notice . Each RSU represents the right to receive one Share as set forth in this Agreement. Participant will have no right to the distribution of any Shares until the time the RSUs have vested. 1.2 Incorporation of Terms of Plan. The RSUs are subject to the terms and conditions set forth in this Agreement and the Plan, which is incorporated herein by reference. In the event of any inconsistency between the Plan...",
"Cover Page Interactive Data File (embedded within the Inline XBRL document)",
"2 US-DOCS\137441470.5 Restructuring) paid by the Participant for such Shares or not issuing any Shares covered by the Award or Prior Plan Award, the unused Shares covered by the Award or Prior Plan Award will, as applicable, become or again be available for Award grants under the Plan. Further, Shares delivered to the Company by a Participant to satisfy the applicable exercise or purchase price of an Award or Prior Plan Award and/or to satisfy any applicable tax withholding obligation with respect to an Award or Prior Plan Award will, as applicable, become or again be available for Award grants under the Plan. The payment of Dividend Equivalents in cash in conjunction with any outstanding Awards or Prior Plan Awards shall not count against the Overall Share Limit. Notwithstanding anything ...",
"2 US-DOCS\138377375.2 c. Payment of Retainers. The annual cash retainers described in Sections 1 and 1 shall be earned on a quarterly basis based on a calendar quarter and shall be paid by the Company in arrears not later than 30 days following the end of each calendar quarter. In the event an Eligible Director does not serve as a director, or in the applicable positions described in Section 1, for an entire calendar quarter, the retainer paid to such Eligible Director shall be prorated for the portion of such calendar quarter actually served as a director, or in such position, as applicable. 2. Equity Compensation. a. General. Eligible Directors shall be granted the equity awards described below. The awards described below shall be granted under and shall be subject to the terms and provi...",
"EXHIBI 10.11",
"EMPLOYMENT AGREEMENT" |
|
07/13/2023 |
******
|
8-K
| Entered into an underwriting agreement for the issuance and sale of notes |
07/07/2023 |
******
|
8-K
| Quarterly results |
07/06/2023 |
******
|
8-K
| Entered into an underwriting agreement for the issuance and sale of notes
Docs:
|
"THIRD Amendment To Agreement AND PLAN OF MERGER THIS THIRD AMENDMENT TO AGREEMENT AND PLAN OF MERGER , dated as of July 5, 2023, is made and entered into by and among MedTech Acquisition Corporation, a Delaware corporation , MTAC Merger Sub, Inc., a Delaware corporation and direct, wholly owned subsidiary of Acquiror , and TriSalus Life Sciences, Inc., a Delaware corporation . Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the Merger Agreement . RECITALS A. WHEREAS, Acquiror, Merger Sub and the Company are parties to that certain Agreement and Plan of Merger, dated as of November 11, 2022, as amended pursuant to that certain First Amendment to Agreement and Plan of Merger, dated as of April 4, 2023 and Second Amendment to Agreement and P...",
"SUBSCRIPTION AGREEMENT",
"Letter re: Termination of Backstop Letter Agreement" |
|
06/30/2023 |
XSNX
|
8-K
| Entered into an underwriting agreement for the issuance and sale of notes |
06/09/2023 |
******
|
8-K
| Entered into an underwriting agreement for the issuance and sale of notes
Docs:
|
"CONVERTIBLE PROMISSORY NOTE Principal Amount: Up to $613,207.55 Dated as of June 5, 2023 Valuence Merger Corp. I, a Cayman Islands exempt company , promises to pay to the order of VMCA Sponsor, LLC, a Cayman Islands limited liability company or its registered assigns or successors in interest , or order, the principal sum of Six Hundred Thirteen Thousand Two Hundred Seven Dollars and Fifty-Five Cents or such lesser amount as has been advanced by Payee to Maker and remains unpaid under this Note on the Maturity Date in lawful money of the United States of America, on the terms and conditions described below. Subject to Section 15 , all payments on this Note shall be made by check or wire transfer of immediately available funds to such account as the Payee may from time to time designate by ...",
"CONVERTIBLE PROMISSORY NOTE Principal Amount: Up to $1,650,943.40 Dated as of June 5, 2023 Valuence Merger Corp. I, a Cayman Islands exempt company , promises to pay to the order of Valuence Partners LP, a Cayman Islands exempted limited partnership or its registered assigns or successors in interest , or order, the principal sum of One Million Six Hundred Fifty Thousand Nine Hundred Forty-Three Dollars and Forty Cents or such lesser amount as has been advanced by Payee to Maker and remains unpaid under this Note on the Maturity Date in lawful money of the United States of America, on the terms and conditions described below. Subject to Section 15 , all payments on this Note shall be made by check or wire transfer of immediately available funds to such account as the Payee may from time to..." |
|
06/08/2023 |
******
|
8-K
| Entered into an underwriting agreement for the issuance and sale of notes |
06/06/2023 |
******
|
8-K
| Entered into an underwriting agreement for the issuance and sale of notes
Docs:
|
"PROMISSORY NOTE",
"Atlantic Coastal Acquisition Corp. Announces Extension of Business Combination Period and Additional Contribution to Trust Account NEW YORK, N.Y. – June 6, 2023 – Atlantic Coastal Acquisition Corp. , a special purpose acquisition corporation, announced that Atlantic Coastal Acquisition Management LLC, the Company’ s initial public offering sponsor , has deposited $80,000 into the Company’ s trust account in order to extend the period of time that the Company has to complete a business combination for an additional one month period, from June 8, 2023 to July 8, 2023. In exchange for the Sponsor’ s additional contribution to the Trust Account, the Company issued a convertible promissory note to the Sponsor in an aggregate principal amount of $80,000. The purpose of the extension is to provid..." |
|
05/23/2023 |
ATHX
|
8-K
| Entered into an underwriting agreement for the issuance and sale of notes |
05/15/2023 |
******
|
8-K
| Entered into an underwriting agreement for the issuance and sale of notes |
05/02/2023 |
XSNX
|
8-K
| Entered into an underwriting agreement for the issuance and sale of notes |
04/06/2023 |
DTGI
|
8-K
| Credit agreement amendment, Entered into an underwriting agreement for the issuance and sale of notes
Docs:
|
"Digerati Technologies, Inc. Convertible Promissory Note Issuance Date: Original Principal Amount: $110,000 Note No. DTGI-10-LGH Consideration Paid at Close: $100,000 FOR VALUE RECEIVED, Digerati Technologies, Inc., a Nevada corporation with a par value of $0.0001 per common share , hereby promises to pay to the order of LGH Investments, LLC, a Wyoming limited liability company or registered assigns the amount set out above as the Original Principal Amount when due, whether upon the Maturity Date , acceleration, redemption or otherwise and to pay interest on any outstanding Principal at the applicable Interest Rate from the date set out above as the Issuance Date until the same becomes due and payable, upon the Maturity Date or acceleration, conversion, redemption or otherwise . The Origina...",
"SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT , dated as of March 7th , 2023, is entered into by and between Digerati Technologies, Inc., a Nevada corporation, , and LGH Investments, LLC, an Wyoming limited liability company . A. The Company and the Buyer are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by the rules and regulations as promulgated by the United States Securities and Exchange Commission under the Securities Act of 1933, as amended . B. Upon the terms and conditions stated in this Agreement, the Buyer desires to purchase and the Company desires to issue and sell, upon the terms and conditions set forth in this Agreement a Convertible Promissory Note of the Company, in the form attached hereto a...",
"SIXTH AMENDMENT TO CREDIT AGREEMENT" |
|
03/27/2023 |
USBL
|
8-K
| Quarterly results |
02/23/2023 |
BNKL
|
8-K
| Entered into an underwriting agreement for the issuance and sale of notes |
01/24/2023 |
SLAT
|
8-K
| Entered into an underwriting agreement for the issuance and sale of notes |
01/05/2023 |
SLAT
|
8-K
| Quarterly results |
12/20/2022 |
BNKL
|
8-K
| Quarterly results |
12/16/2022 |
******
|
8-K
| Entered into an underwriting agreement for the issuance and sale of notes |
12/13/2022 |
XSNX
|
8-K
| Quarterly results |
12/06/2022 |
******
|
8-K
| Director compensation was amended/approved, Acquisition/merger/asset purchase announced, Entered into an underwriting agreement for the issuance and sale of notes
Docs:
|
"WHEREAS, Acquiror is a blank check company incorporated as a Cayman Islands exempted company and incorporated for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses; WHEREAS, Acquiror, Merger Sub and the Company previously entered into that certain Agreement and Plan of Merger, dated as of October 13, 2021 , as amended on July 1, 2022",
"Amendment.",
"Amendment.",
"CERTIFICATE OF INCORPORATION OF",
"Bylaws of   Tempo Automation Holdings, Inc.  ",
"TEMPO AUTOMATION HOLDINGS, INC. INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE COMMON STOCK This Certifies that is the owner of FULLY PAID AND NON-ASSESSABLE SHARES OF COMMON STOCK, PAR VALUE OF $0.0001 PER SHARE, OF TEMPO AUTOMATION HOLDINGS, INC. transferable on the books of the Company in person or by duly authorized attorney upon surrender of this certificate properly endorsed. This certificate is not valid unless countersigned by the Transfer Agent and registered by the Registrar. Witness the seal of the Company and the facsimile signatures of its duly authorized officers. Secretary [Corporate Seal] Delaware Chief Executive Officer TEMPO AUTOMATION HOLDINGS, INC.",
"Warrants THIS WARRANT SHALL BE VOID IF NOT EXERCISED PRIOR TO THE EXPIRATION OF THE EXERCISE PERIOD PROVIDED FOR IN THE WARRANT AGREEMENT DESCRIBED BELOW",
"Enhance our automated, intelligent process to benefit the customer experience. As we take more orders, we accumulate more data. More data helps us deliver a better customer experience, which, in turn, drives more orders — a virtuous cycle. Further, additional orders yield additional gross profit, which we can use to accelerate our R&D investment in our software platform",
"Enhance our automated, intelligent process to benefit the customer experience. As we take more orders, we accumulate more data. More data helps us deliver a better customer experience, which, in turn, drives more orders — a virtuous cycle. Further, additional orders yield additional gross profit, which we can use to accelerate our R&D investment in our software platform",
"Enhance our automated, intelligent process to benefit the customer experience. As we take more orders, we accumulate more data. More data helps us deliver a better customer experience, which, in turn, drives more orders — a virtuous cycle. Further, additional orders yield additional gross profit, which we can use to accelerate our R&D investment in our software platform" |
|
11/29/2022 |
******
|
8-K
| Quarterly results |
11/17/2022 |
BNKL
|
8-K
| Quarterly results |
11/09/2022 |
XSNX
|
8-K
| Quarterly results |
11/08/2022 |
PHOT
|
8-K
| Quarterly results |
10/13/2022 |
IMHC
|
8-K
| Entered into an underwriting agreement for the issuance and sale of notes |
10/13/2022 |
******
|
8-K
| Entered into an underwriting agreement for the issuance and sale of notes |
09/30/2022 |
******
|
8-K
| Quarterly results |
09/29/2022 |
XSNX
|
8-K
| Entered into an underwriting agreement for the issuance and sale of notes |
09/27/2022 |
******
|
8-K
| Director compensation was amended/approved, Entered into an underwriting agreement for the issuance and sale of notes
Docs:
|
"Second Amended & Restated Certificate of Incorporation",
"Bylaws of Presto Automation Inc",
"METROPOLITAN PARTNERS GROUP ADMINISTRATION, LLC, as Agent",
"Amended & Restated Registration Rights Agreement, by and among New Presto, the Sponsors, Cleveland Avenue, VTAQ’s officers and directors, Metropolitan and certain Legacy Presto stockholders",
"Amended & Restated Warrant Agreement, by and among, New Presto, the Sponsors and Continental Stock Transfer & Trust Company",
"Cover Page Interactive Data File (embedded within the Inline XBRL document)",
"Form of Indemnification Agreement",
"PRESTO AUTOMATION INC. 2022 INCENTIVE AWARD PLAN",
"PRESTO AUTOMATION INC. 2022 EMPLOYEE STOCK PURCHASE PLAN",
"Presto, One of the Largest Labor Automation Technology Providers for the Hospitality Industry, to Become Publicly Traded Following Business Combination with Ventoux CCM Acquisition Corp." |
|
08/25/2022 |
******
|
8-K
| Quarterly results |
08/22/2022 |
******
|
8-K
| Entered into an underwriting agreement for the issuance and sale of notes |
08/09/2022 |
XSNX
|
8-K
| Entered into an underwriting agreement for the issuance and sale of notes |
|
|
|